fbpx
Southwestern

Lauran Neergaard

Sort by:
Filter by Resource Type:
Filter Options »
Filter by Topic:
Filter by Scripture:
Filter by Series:
Filter by Event:
Filter by Media Format:

2nd COVID-19 vaccine set for OK in US with panel endorsement

WASHINGTON (AP) — A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.

‘Relieved’: US health workers start getting COVID-19 vaccine

The biggest vaccination campaign in U.S. history kicked off Monday (Dec. 14) as health workers rolled up their sleeves for shots to protect them from COVID-19 and start beating back the pandemic — a day of optimism even as the nation's death toll closed in on 300,000.

Pfizer vaccine moves closer to getting the OK in the US

WASHINGTON (AP) — U.S. regulators Tuesday released their first scientific evaluation of Pfizer's COVID-19 vaccine and confirmed it offers strong protection, setting the stage for the government to green-light the biggest vaccination effort in the nation's history.

Moderna asking US, European regulators to OK its virus shots

(AP) – Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection.

Pfizer seeking emergency use of its COVID-19 vaccine in US

Pfizer said Friday (Nov. 20) it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic – but not until after a long, hard winter.

2nd virus vaccine shows overwhelming success in U.S. tests

CAMBRIDGE, Mass. (AP) -- Moderna said Monday its COVID-19 vaccine is proving to be highly effective in a major trial, a second dash of hope in the global race for a shot to tame a resurgent virus that is now killing more than 8,000 people a day worldwide.

Pfizer says COVID-19 vaccine is looking 90% effective

Pfizer said Monday that an early peek at the data on its coronavirus vaccine suggests the shots may be a surprisingly robust 90 percent effective at preventing COVID-19, putting the company on track to apply later this month for emergency-use approval from the Food and Drug Administration.

First COVID-19 vaccine tested in US poised for final testing

BETHESDA, Md. (AP) -- The first COVID-19 vaccine tested in the U.S. revved up people's immune systems just the way scientists had hoped, researchers reported Tuesday -- as the shots are poised to begin key final testing. "No matter how you slice this, this is good news," Dr. Anthony Fauci, the U.S. government's top infectious disease expert, told The Associated Press.